Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Plc Closes $30M Funding Round

NEW YORK – Genomics plc said Monday that it has completed a $30 million funding round.

Previous investors Foresight Capital and F-Prime Capital led the unnamed round, with participation from Oxford Sciences Innovation and Lansdowne Partners.

The Oxford, UK-based genome analysis company said it would use the proceeds to "expand its work" in the area of genomic prevention.

"This new approach to healthcare, called genomic prevention, can identify people at risk for developing each disease early, and is critical to driving more efficient screening and a prevention-first approach to healthcare. More successful disease prevention will improve patient lives and make healthcare systems more sustainable," Genomics Cofounder and CEO Peter Donnelly said in a statement.

Stephen Knight, president and managing partner of F-Prime Capital, said that Genomics works at the nexus of data sciences and life sciences. "The company's proprietary research platform powered by a large dataset of genotypic and phenotypic information, combined with the leading statistical genomics team in the world, deliver unique insights in the discovery of new therapeutic targets as well as key advancements in preventative healthcare," said Knight, a member of the Genomics board.

Genomics previously raised £33 million ($45.8 million) in a Series B round in late 2018.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.